Recent Finacing
Recent Raise
ANeuroTech is a Belgium-based clinical-stage biotech developing ANT-01, a once-daily 15 mg oral pipamperone adjunct to SSRIs/SNRIs for MDD, with an FDA IND for Phase IIIB.
Recent Investors
Funding round
Investor
See the team members at ANeuroTech.
